TOT BIOPHARM INTL CO LTD revenue breakdown overview

TOT BIOPHARM INTL CO LTD revenue for the last year amounted to 858.80 M HKD, the most of which — 862.59 M HKD — came from its highest performing source at the moment, Anti-tumor Drugs and Self-developed Biological Drugs, the year earlier bringing 514.20 M HKD. The greatest contribution to the revenue figure was made by China — last year it brought TOT BIOPHARM INTL CO LTD 862.59 M HKD, and the year before that — 514.20 M HKD.